Prospects for Rational Development of Pharmacological Gap Junction Channel Blockers
The DOI matches its Crossref record.
Abstract
Connexin-null mice and human genetic gap junction diseases illustrate the important roles that gap junction channels play under normal conditions, and the neuro- and cardioprotective effects of gap junction blocking agents demonstrate that closure of these channels may be beneficial in certain pathological situations. This overview summarizes studies in which gap junction modifying reagents have been characterized, highlighting examples of agents for which selectivity for gap junction subtypes has been demonstrated. In addition, strategies for targeting connexin domains through peptide inhibitors are outlined, which may ultimately provide agents that are not only connexin-selective in their actions, but also affect only a subset of a gap junction channel's gating responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrin, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,431
Astroglial networks: a step further in neuroglial and gliovascular interactions
Giaume, C., Koulakoff, A., Roux, L., Holcman, D., & Rouach, N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2757 · Cited by 777
P2X7Receptors Mediate ATP Release and Amplification of Astrocytic Intercellular Ca2+Signaling
Suadicani, S. O., Brosnan, C. F., & Scemes, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3902-05.2006 · Cited by 512
The P2X 7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X 7 R Pore
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374
“…oxATP inhibits both conductance states, while agents such as carbenoxolone, a gap junction (connexin hemichannel) blocker (Davidson et al., 1986; Spray et al., 2002) with antagonistic potential for P2X7R (Iglesias et al., 2008), has a myriad of confounding anti- inflammatory (Suzuki et al.,…”
BackgroundRavier, M. A., Güldenagel, M., Charollais, A., Gjinovci, A., Caille, D., Söhl, G., Wollheim, C. B., Willecke, K., Henquin, J.-C., & Meda, P. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1798 · Cited by 360
“Several studies measuring [Ca(2) ]i in whole islets or clusters of islet cells have indirectly supported this interpretation (5,17,24,25) but could not conclusively prove it, mainly because specific inhibitors of connexin channels are not yet available (26).”
ResultPotent block of Cx36 and Cx50 gap junction channels by mefloquine
Cruikshank, S. J., Hopperstad, M., Younger, M., Connors, B. W., Spray, D. C., & Srinivas, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402044101 · Cited by 350
Intercellular Ca2+Waves: Mechanisms and Function
Leybaert, L., & Sanderson, M. J. (2012) · Physiological Reviews · doi:10.1152/physrev.00029.2011 · Cited by 331
Functional connexin “hemichannels”: A critical appraisal
Spray, D. C., Ye, Z., & Ransom, B. R. (2006) · Glia · doi:10.1002/glia.20429 · Cited by 319
Juszczak, G. R., & Swiergiel, A. H. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.014 · Cited by 211
“For example, conductance is increased by intracellular alkalinization and decreased by acidification although not all connexins are equally sensitive to changes in pH (Spray et al., 2002).”
BackgroundInfluentialConnexins: Key Mediators of Endocrine Function
Bosco, D., Haefliger, J.-A., & Meda, P. (2011) · Physiological Reviews · doi:10.1152/physrev.00027.2010 · Cited by 169
Metadata
- Authors
- David C. Spray, B. S. P., Renato Rozental, B. S. P., & Miduturu Srinivas, B. S. P.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2002-12-01
- Volume
- 3
- Issue
- 6
- Pages
- 455-464
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2153921203
- Cited by
- 76
- References
- 0
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.